KZIA insider transaction filings
KAZIA THERAPEUTICS LTD — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-08. Screen KZIA transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 6 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Friend John E. II — Chief Executive Officer | 1 | — | — | 2 |
| APPLE ROBERT F — Director | 1 | — | — | 1 |
| Bonacorda Jeffrey — VP, Finance and Controller | 1 | — | — | 1 |
| Cain David — Director, CMC | 1 | — | — | 1 |
| Coffey Steven R. S. — Director | 1 | — | — | 1 |
| Davidson Ebru — Director | 1 | — | — | 1 |
Recent Form 4 filings — KAZIA THERAPEUTICS LTD
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-08 | 4 | Coffey Steven R. S. — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Friend John E. II — Chief Executive Officer | Grant/award (A): 500,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Bonacorda Jeffrey — VP, Finance and Controller | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Davidson Ebru — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Cain David — Director, CMC | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | APPLE ROBERT F — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Levine James E. — Chief Financial Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Rao Sudha — Chief Scientific Officer | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KZIA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →